Magnisense moved its R&D Lab to “Le Campus”, a new facility in Lyon, at the heart of the worldwide healthcare competitive cluster Lyon biopole. Its headquarter is located in Paris, at the heart of Medicen.
Magnisense, The Emergency Diag to save lives.
Magnisense designs and develops proprietary diagnostic tests for cardio-vascular diseases, based on its patented breakthrough technology (MIAtek®). After several years of R&D, the final product is to reach the market.
This product which consists in a mobile device and consumables, will allow the medical practitioners to diagnose cardio-vascular events in emergency situations, in particular for heart attack, by quantifying in 15 minutes cardiac bio-markers directly from whole blood. Intellectual property consists of a ringe fenced portfolio 20+ granted patents worldwide.